福瑞达（600223）：收入利润短期承压，静候化妆品新品放量

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative price increase of over 15% in the next six months [4][14]. Core Insights - The company's revenue and profit have faced short-term pressure due to the core cosmetic products being in a product iteration phase, leading to a year-on-year revenue decline of 7.34% to 2.597 billion yuan and a net profit decline of 17.19% to 142 million yuan for the first three quarters of 2025 [2][4]. - The cosmetic segment is expected to recover as new products gain traction, while the raw materials business is transitioning to higher-end products, which should enhance profit margins [4]. Summary by Sections Revenue and Profit Performance - For the first three quarters of 2025, the company achieved revenue of 2.597 billion yuan, down 7.34% year-on-year, primarily due to the core cosmetic products being in an iteration phase and new product sales not reaching sufficient scale [2]. - The net profit attributable to the parent company was 142 million yuan, a decrease of 17.19% year-on-year [2]. Profitability and Cost Structure - The gross margin for the company decreased by 0.38 percentage points to 51.47%, mainly due to a decline in the gross margin of the cosmetic business [2]. - The net profit margin also fell by 0.61 percentage points to 6.87%, with sales expenses slightly down by 0.08 percentage points to 36.39%, while management and R&D expense ratios increased by 0.63 and 0.77 percentage points, respectively [2]. Future Earnings Forecast - The report adjusts the profit forecast for the company, estimating net profits of 213 million yuan, 254 million yuan, and 292 million yuan for 2025, 2026, and 2027, respectively [4]. - The corresponding price-to-earnings ratios for these years are projected to be 37, 32, and 27 times based on the closing price on October 27, 2025 [4].